Buy me a coffee
Home › FDA recalls › Pantoprazole Sodium
CLASS II · ModerateFDA

Hetero Labs Limited (Unit V) recalls Pantoprazole Sodium

📅 Mar 26, 2026 · 📍 Nationwide
Recalling company
Hetero Labs Limited (Unit V)
Product
Pantoprazole Sodium, Delayed-Release Tablets, USP, 40 mg, 1000-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: Hetero, Hetero Labs Limited, Unit V, Polepally, Jadcherta, Mahabubager-509 301, India, NDC 31722-713-10
Reason
Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots."
Classification
Class II – may cause temporary or medically reversible health consequences
Recall date
Mar 26, 2026
Reported
Apr 29, 2026
Distribution
Nationwide in the USA.
Status
Ongoing
Quantity
4,740 1,000-count bottles.
Lot / codes
Batch # FD253967, Exp Date: 06/26/2027
Company location
Mahabubnagar, N/A
Recall type
Voluntary: Firm initiated
Recall number
D-0484-2026
Agency
U.S. Food and Drug Administration (FDA)

View official FDA notice ↗ Search recall number D-0484-2026 in the FDA Enforcement Report. Also see FDA recall press releases.

If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.